PUBLIC CONTRACT · 2025
Medic. Idarucizumab / Levofolinato Dissódico / Mesna / Tiamina
- Contract value
- €10,343.88
- Signed on
- 13 November 2025
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 12718636PUBLISHED SUBJECT
41/257/2026 - Medic. Idarucizumab / Levofolinato Dissódico / Mesna / Tiamina
Parties involved
- Place of performance
- Portugal, Faro, Faro
- NUTS region
- PT150 - Algarve
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- MEDAC · Tax ID 980369959
- Awardee
- Baxter Médico Farmacêutica, Lda · Tax ID 503347345
- Awardee
- Boehringer Ingelheim Portugal, Lda · Tax ID 500293023
Values and timeline
- Contract price
- €10,343.88
- Procedure base price
- €10,343.88
- Total effective price
- Not reported on Portal BASE
- Publication date
- 21 January 2026
- Award date
- 13 November 2025
- Signing date
- 13 November 2025
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- 437/2023 - Medicação antialérgica, vitaminas e sais minerais e medicamentos usados no tratamento de intoxicações
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 8784818
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.